Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d).
Breslin HJ, Diamond CJ, Kavash RW, Cai C, Dyatkin AB, Miskowski TA, Zhang SP, Wade PR, Hornby PJ, He W. Breslin HJ, et al. Among authors: miskowski ta. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4869-72. doi: 10.1016/j.bmcl.2012.05.042. Epub 2012 May 24. Bioorg Med Chem Lett. 2012. PMID: 22695132
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.
Ralbovsky JL, Lisko JG, Palmer JM, Mabus J, Chevalier KM, Schulz MJ, Dyatkin AB, Miskowski TA, Coats SJ, Hornby P, He W. Ralbovsky JL, et al. Among authors: miskowski ta. Bioorg Med Chem Lett. 2009 May 15;19(10):2661-3. doi: 10.1016/j.bmcl.2009.03.157. Epub 2009 Apr 5. Bioorg Med Chem Lett. 2009. PMID: 19375913
Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonists.
Gong Y, Kent Barbay J, Kimball ES, Santulli RJ, Carolyn Fisher M, Dyatkin AB, Miskowski TA, Hornby PJ, He W. Gong Y, et al. Among authors: miskowski ta. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1331-5. doi: 10.1016/j.bmcl.2008.01.022. Epub 2008 Jan 11. Bioorg Med Chem Lett. 2008. PMID: 18226905
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists.
Gong Y, Barbay JK, Dyatkin AB, Miskowski TA, Kimball ES, Prouty SM, Fisher MC, Santulli RJ, Schneider CR, Wallace NH, Ballentine SA, Hageman WE, Masucci JA, Maryanoff BE, Damiano BP, Andrade-Gordon P, Hlasta DJ, Hornby PJ, He W. Gong Y, et al. Among authors: miskowski ta. J Med Chem. 2006 Jun 1;49(11):3402-11. doi: 10.1021/jm060031q. J Med Chem. 2006. PMID: 16722660
Identification of potent phenyl imidazoles as opioid receptor agonists.
Breslin HJ, Cai C, Miskowski TA, Coutinho SV, Zhang SP, Hornby P, He W. Breslin HJ, et al. Among authors: miskowski ta. Bioorg Med Chem Lett. 2006 May 1;16(9):2505-8. doi: 10.1016/j.bmcl.2006.01.082. Epub 2006 Feb 17. Bioorg Med Chem Lett. 2006. PMID: 16483774
Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonists.
Dyatkin AB, Gong Y, Miskowski TA, Kimball ES, Prouty SM, Fisher MC, Santulli RJ, Schneider CR, Wallace NH, Hornby PJ, Diamond C, Kinney WA, Maryanoff BE, Damiano BP, He W. Dyatkin AB, et al. Among authors: miskowski ta. Bioorg Med Chem. 2005 Dec 15;13(24):6693-702. doi: 10.1016/j.bmc.2005.07.022. Epub 2005 Aug 19. Bioorg Med Chem. 2005. PMID: 16112583
Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disorders.
Breslin HJ, Miskowski TA, Rafferty BM, Coutinho SV, Palmer JM, Wallace NH, Schneider CR, Kimball ES, Zhang SP, Li J, Colburn RW, Stone DJ, Martinez RP, He W. Breslin HJ, et al. Among authors: miskowski ta. J Med Chem. 2004 Oct 7;47(21):5009-20. doi: 10.1021/jm030548r. J Med Chem. 2004. PMID: 15456245
Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indoles.
Breslin HJ, Miskowski TA, Kukla MJ, Leister WH, De Winter HL, Gauthier DA, Somers MV, Peeters DC, Roevens PW. Breslin HJ, et al. Among authors: miskowski ta. J Med Chem. 2002 Nov 21;45(24):5303-10. doi: 10.1021/jm0202831. J Med Chem. 2002. PMID: 12431057
Tripeptidyl-peptidase II (TPP II) inhibitory activity of (S)-2,3-dihydro-2-(1H-imidazol-2-yl)-1H-indoles, a systematic SAR evaluation. Part 2.
Breslin HJ, Miskowski TA, Kukla MJ, De Winter HL, Somers MV, Roevens PW, Kavash RW. Breslin HJ, et al. Among authors: miskowski ta. Bioorg Med Chem Lett. 2003 Dec 15;13(24):4467-71. doi: 10.1016/j.bmcl.2003.09.014. Bioorg Med Chem Lett. 2003. PMID: 14643348
Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activities.
Lee SJ, Konishi Y, Yu DT, Miskowski TA, Riviello CM, Macina OT, Frierson MR, Kondo K, Sugitani M, Sircar JC, et al. Lee SJ, et al. Among authors: miskowski ta. J Med Chem. 1995 Sep 1;38(18):3547-57. doi: 10.1021/jm00018a014. J Med Chem. 1995. PMID: 7658441
11 results
Jump to page
Feedback